Suppr超能文献

急性肝衰竭。

Acute liver failure.

机构信息

Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.

Department of Hepatology, Asian Institute of Gastroenterology, Hyderabad, India.

出版信息

Lancet. 2024 Aug 24;404(10454):789-802. doi: 10.1016/S0140-6736(24)00693-7. Epub 2024 Aug 1.

Abstract

Acute liver failure (ALF) is a life-threatening disorder characterised by rapid deterioration of liver function, coagulopathy, and hepatic encephalopathy in the absence of pre-existing liver disease. The cause of ALF varies across the world. Common causes of ALF in adults include drug toxicity, hepatotropic and non-hepatotropic viruses, herbal and dietary supplements, antituberculosis drugs, and autoimmune hepatitis. The cause of liver failure affects the management and prognosis, and therefore extensive investigation for cause is strongly suggested. Sepsis with multiorgan failure and cerebral oedema remain the leading causes of death in patients with ALF and early identification and appropriate management can alter the course of ALF. Liver transplantation is the best current therapy, although the role of artificial liver support systems, particularly therapeutic plasma exchange, can be useful for patients with ALF, especially in non-transplant centres. In this Seminar, we discuss the cause, prognostic models, and management of ALF.

摘要

急性肝衰竭(ALF)是一种危及生命的疾病,其特征为无先前存在的肝脏疾病的情况下,肝功能迅速恶化、凝血功能障碍和肝性脑病。ALF 的病因在世界各地有所不同。成人 ALF 的常见病因包括药物毒性、嗜肝和非嗜肝病毒、草药和膳食补充剂、抗结核药物和自身免疫性肝炎。肝衰竭的病因影响治疗和预后,因此强烈建议进行广泛的病因调查。败血症伴多器官衰竭和脑水肿仍然是 ALF 患者死亡的主要原因,早期识别和适当的治疗可以改变 ALF 的病程。肝移植是目前最好的治疗方法,尽管人工肝支持系统,特别是治疗性血浆置换,对 ALF 患者可能有用,尤其是在非移植中心。在本次研讨会上,我们将讨论 ALF 的病因、预后模型和治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验